Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis-Reference-Cited by-同舟云学术

Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis

Published:2002-01-15 Issue:2 Volume:94 Page:492-499
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Rossi Carlo R.,Foletto Mirto,Mocellin Simone,Pilati Pierluigi,De Simone Michele,Deraco Marcello,Cavaliere Francesco,Palatini Pietro,Guasti Fabiola,Scalerta Romano,Lise Mario

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference63 articles.

1. Peritioneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors

2. Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management.

3. Retroperitoneal Soft-Tissue Sarcoma

4. Intraperitoneal chemotherapy: a review.

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: HIPEC Technologies;Annals of Surgical Oncology;2024-07-22

2. Impact of Perioperative Systemic Chemotherapy on Survival for Patients Who have Diffuse Malignant Peritoneal Mesothelioma Treated with CRS–HIPEC;Annals of Surgical Oncology;2023-11-08

3. Peritoneal Mesothelioma: Systematic Review of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Protocol Outcomes;Indian Journal of Surgical Oncology;2023-03-04

4. Translational and pharmacological principles of hyperthermic intraperitoneal chemotherapy for ovarian cancer;Best Practice & Research Clinical Obstetrics & Gynaecology;2022-01

5. Phase II randomized study on tissue distribution and pharmacokinetics of cisplatin according to different levels of intra-abdominal pressure (IAP) during HIPEC (NCT02949791);European Journal of Surgical Oncology;2021-01